Medications for Nephrosis

3 results
  • Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
    Usage: ALBUMIN (HUMAN) 25% is indicated for treating hypovolemia, hypoalbuminemia in critically ill or active bleeding patients, maintaining cardiovascular function post-paracentesis for cirrhotic ascites, managing severe ovarian hyperstimulation syndrome, adjunct treatment for ARDS and acute nephrosis, and treating hyperbilirubinemia in hemolytic disease of the newborn.
  • Flexbumin

    (Albumin Human)
    Takeda Pharmaceuticals America, Inc.
    Usage: FLEXBUMIN® 25% is indicated for treating hypovolemia, hypoalbuminemia, conditions associated with severe injuries or infections, adult respiratory distress syndrome, nephrosis, assisting in cardiopulmonary bypass surgery, and for infants with severe hemolytic disease of the newborn to manage unconjugated bilirubin. It is not an intravenous nutrient.
  • Takeda Pharmaceuticals America, Inc.
    Usage: FLEXBUMIN® 20% (Albumin [Human]) is indicated for hypovolemia, hypoalbuminemia, cardiopulmonary bypass surgery, and hemolytic disease of the newborn (HDN). It treats inadequate albumin levels due to various conditions including burns, infections, and severe injuries, and is used in specific surgical settings for blood dilution.